Big cohort studies offer insights into preventable risk factors
- PMID: 34480539
- PMCID: PMC8560205
- DOI: 10.1093/eurheartj/ehab566
Big cohort studies offer insights into preventable risk factors
Comment in
-
Cerebrotoxicity of antihypertensive therapy in the UK Biobank Cohort Study.Eur Heart J. 2021 Nov 1;42(41):4282. doi: 10.1093/eurheartj/ehab567. Eur Heart J. 2021. PMID: 34480536 No abstract available.
Comment on
-
Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study.Eur Heart J. 2021 Feb 14;42(7):750-757. doi: 10.1093/eurheartj/ehaa756. Eur Heart J. 2021. PMID: 33238300 Free PMC article.
-
On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics.Eur Heart J. 2021 Feb 14;42(7):758-760. doi: 10.1093/eurheartj/ehaa971. Eur Heart J. 2021. PMID: 33369623 No abstract available.
References
-
- Messerli FH, Bavishi C, Messerli AW, Siontis GCM. On cerebrotoxicity of antihypertensive therapy and risk factor cosmetics. Eur Heart J 2021;42:758–760. - PubMed
-
- Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103–2116. - PMC - PubMed
-
- Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–967. - PubMed
